Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 49

1.

Assessment of the Minimal Targeted Biopsy Core Number per MRI Lesion for Improving Prostate Cancer Grading Prediction.

Ploussard G, Beauval JB, Renard-Penna R, Lesourd M, Manceau C, Almeras C, Gautier JR, Loison G, Portalez D, Salin A, Soulié M, Tollon C, Malavaud B, Roumiguié M.

J Clin Med. 2020 Jan 15;9(1). pii: E225. doi: 10.3390/jcm9010225.

2.

Imaging protocols for renal multiparametric MRI and MR urography: results of a consensus conference from the French Society of Genitourinary Imaging.

Rouvière O, Cornelis F, Brunelle S, Roy C, André M, Bellin MF, Boulay I, Eiss D, Girouin N, Grenier N, Hélénon O, Lapray JF, Lefèvre A, Matillon X, Ménager JM, Millet I, Ronze S, Sanzalone T, Tourniaire J, Rocher L, Renard-Penna R; “French Society of Genitourinary Imaging Consensus group”.

Eur Radiol. 2020 Jan 3. doi: 10.1007/s00330-019-06530-z. [Epub ahead of print]

PMID:
31900706
3.

Imaging protocols for CT urography: results of a consensus conference from the French Society of Genitourinary Imaging.

Renard-Penna R, Rocher L, Roy C, André M, Bellin MF, Boulay I, Eiss D, Girouin N, Grenier N, Hélénon O, Lapray JF, Lefèvre A, Matillon X, Ménager JM, Millet I, Ronze S, Sanzalone T, Tourniaire J, Brunelle S, Rouvière O; “French Society of Genitourinary Imaging Consensus group”.

Eur Radiol. 2020 Mar;30(3):1387-1396. doi: 10.1007/s00330-019-06529-6. Epub 2019 Dec 17.

PMID:
31848742
4.

EAU-EANM-ESTRO-ESUR-SIOG Prostate Cancer Guideline Panel Consensus Statements for Deferred Treatment with Curative Intent for Localised Prostate Cancer from an International Collaborative Study (DETECTIVE Study).

Lam TBL, MacLennan S, Willemse PM, Mason MD, Plass K, Shepherd R, Baanders R, Bangma CH, Bjartell A, Bossi A, Briers E, Briganti A, Buddingh KT, Catto JWF, Colecchia M, Cox BW, Cumberbatch MG, Davies J, Davis NF, De Santis M, Dell'Oglio P, Deschamps A, Donaldson JF, Egawa S, Fankhauser CD, Fanti S, Fossati N, Gandaglia G, Gillessen S, Grivas N, Gross T, Grummet JP, Henry AM, Ingels A, Irani J, Lardas M, Liew M, Lin DW, Moris L, Omar MI, Pang KH, Paterson CC, Renard-Penna R, Ribal MJ, Roobol MJ, Rouprêt M, Rouvière O, Sancho Pardo G, Richenberg J, Schoots IG, Sedelaar JPM, Stricker P, Tilki D, Vahr Lauridsen S, van den Bergh RCN, Van den Broeck T, van der Kwast TH, van der Poel HG, van Leenders GJLH, Varma M, Violette PD, Wallis CJD, Wiegel T, Wilkinson K, Zattoni F, N'Dow JMO, Van Poppel H, Cornford P, Mottet N.

Eur Urol. 2019 Dec;76(6):790-813. doi: 10.1016/j.eururo.2019.09.020. Epub 2019 Oct 3. Review.

PMID:
31587989
5.

MRI for prostate cancer: can computed high b-value DWI replace native acquisitions?

Jendoubi S, Wagner M, Montagne S, Ezziane M, Mespoulet J, Comperat E, Estellat C, Baptiste A, Renard-Penna R.

Eur Radiol. 2019 Oct;29(10):5197-5204. doi: 10.1007/s00330-019-06085-z. Epub 2019 Mar 18.

PMID:
30887197
6.

The future of molecular and functional imaging in prostate cancer.

Renard-Penna R, Gauthé M.

Arch Esp Urol. 2019 Mar;72(2):150-156. Review.

PMID:
30855016
7.

[Diagnostic procedure for acute kidney failure].

Tamzali Y, Drouin S, Renard-Penna R, Hertig A.

Rev Prat. 2018 Feb;68(2):152-156. French.

PMID:
30801140
8.

Use of prostate systematic and targeted biopsy on the basis of multiparametric MRI in biopsy-naive patients (MRI-FIRST): a prospective, multicentre, paired diagnostic study.

Rouvière O, Puech P, Renard-Penna R, Claudon M, Roy C, Mège-Lechevallier F, Decaussin-Petrucci M, Dubreuil-Chambardel M, Magaud L, Remontet L, Ruffion A, Colombel M, Crouzet S, Schott AM, Lemaitre L, Rabilloud M, Grenier N; MRI-FIRST Investigators.

Lancet Oncol. 2019 Jan;20(1):100-109. doi: 10.1016/S1470-2045(18)30569-2. Epub 2018 Nov 21.

PMID:
30470502
9.

Update on the ICUD-SIU consultation on multi-parametric magnetic resonance imaging in localised prostate cancer.

Barret E, Turkbey B, Puech P, Durand M, Panebianco V, Fütterer JJ, Renard-Penna R, Rouvière O.

World J Urol. 2019 Mar;37(3):429-436. doi: 10.1007/s00345-018-2395-3. Epub 2018 Jul 12. Review.

PMID:
30003373
10.

Editorial Comment: Advances in MRI and PET of the prostate: concurrence or complementarity?

Renard-Penna R, Gauthé M, Talbot JN.

Eur Radiol. 2018 Aug;28(8):3138-3140. doi: 10.1007/s00330-018-5459-2. Epub 2018 Jun 1.

PMID:
29858639
11.

Multiparametric MRI for Suspected Recurrent Prostate Cancer after HIFU:Is DCE still needed?

Lotte R, Lafourcade A, Mozer P, Conort P, Barret E, Comperat E, Ezziane M, de Guibert PJ, Tavolaro S, Belin L, Boudghene F, Lucidarme O, Renard-Penna R.

Eur Radiol. 2018 Sep;28(9):3760-3769. doi: 10.1007/s00330-018-5352-z. Epub 2018 Apr 9.

PMID:
29633004
12.

Typology of intravesical prostatic protrusions, or so-called median lobes, in middle-aged and older men.

Audouin M, Girshovich A, Cussenot O, Renard-Penna R.

Surg Radiol Anat. 2018 Apr;40(4):389-393. doi: 10.1007/s00276-018-1999-z. Epub 2018 Mar 13.

PMID:
29536129
13.

Dynamic contrast-enhanced imaging in localizing local recurrence of prostate cancer after radiotherapy: Limited added value for readers of varying level of experience.

Luzurier A, Jouve De Guibert PH, Allera A, Feldman SF, Conort P, Simon JM, Mozer P, Compérat E, Boudghene F, Servois V, Lucidarme O, Granger B, Renard-Penna R.

J Magn Reson Imaging. 2018 Oct;48(4):1012-1023. doi: 10.1002/jmri.25991. Epub 2018 Mar 8.

PMID:
29517822
14.

[Role of prostate MRI, TRUS fusion biopsies and new markers in the diagnostic strategy of prostate cancer].

Renard-Penna R, Mozer P, Lunelli L, Cussenot O.

Presse Med. 2017 Oct;46(10):928-934. doi: 10.1016/j.lpm.2017.03.017. Epub 2017 May 11. French.

PMID:
28502474
15.

Reporting Magnetic Resonance Imaging in Men on Active Surveillance for Prostate Cancer: The PRECISE Recommendations-A Report of a European School of Oncology Task Force.

Moore CM, Giganti F, Albertsen P, Allen C, Bangma C, Briganti A, Carroll P, Haider M, Kasivisvanathan V, Kirkham A, Klotz L, Ouzzane A, Padhani AR, Panebianco V, Pinto P, Puech P, Rannikko A, Renard-Penna R, Touijer K, Turkbey B, van Poppel H, Valdagni R, Walz J, Schoots I.

Eur Urol. 2017 Apr;71(4):648-655. doi: 10.1016/j.eururo.2016.06.011. Epub 2016 Jun 24.

PMID:
27349615
16.

HOXB13 protein expression in metastatic lesions is a promising marker for prostate origin.

Varinot J, Furudoï A, Drouin S, Phe V, Penna RR, Roupret M, Bitker MO, Cussenot O, Compérat E.

Virchows Arch. 2016 May;468(5):619-22. doi: 10.1007/s00428-016-1917-x. Epub 2016 Mar 1.

PMID:
26931741
17.

Apparent diffusion coefficient value is a strong predictor of unsuspected aggressiveness of prostate cancer before radical prostatectomy.

Renard Penna R, Cancel-Tassin G, Comperat E, Mozer P, Léon P, Varinot J, Roupret M, Bitker MO, Lucidarme O, Cussenot O.

World J Urol. 2016 Oct;34(10):1389-95. doi: 10.1007/s00345-016-1789-3. Epub 2016 Feb 22.

PMID:
26902878
18.

Contemporary role of lymph node dissection at the time of radical nephroureterectomy for upper tract urothelial carcinoma.

Seisen T, Shariat SF, Cussenot O, Peyronnet B, Renard-Penna R, Colin P, Rouprêt M.

World J Urol. 2017 Apr;35(4):535-548. doi: 10.1007/s00345-016-1764-z. Epub 2016 Jan 25. Review.

PMID:
26809456
19.

Oncologic Outcomes of Kidney Sparing Surgery versus Radical Nephroureterectomy for the Elective Treatment of Clinically Organ Confined Upper Tract Urothelial Carcinoma of the Distal Ureter.

Seisen T, Nison L, Remzi M, Klatte T, Mathieu R, Lucca I, Bozzini G, Capitanio U, Novara G, Cussenot O, Compérat E, Renard-Penna R, Peyronnet B, Merseburger AS, Fritsche HM, Hora M, Shariat SF, Colin P, Rouprêt M.

J Urol. 2016 May;195(5):1354-1361. doi: 10.1016/j.juro.2015.11.036. Epub 2015 Nov 21.

PMID:
26612196
20.

Relationship between non-suspicious MRI and insignificant prostate cancer: results from a monocentric study.

Renard-Penna R, Roupret M, Compérat E, Rozet F, Granger B, Barkatz J, Bitker MO, Lucidarme O, Cussenot O, Mozer P.

World J Urol. 2016 May;34(5):673-8. doi: 10.1007/s00345-015-1685-2. Epub 2015 Sep 24.

PMID:
26403663

Supplemental Content

Loading ...
Support Center